mortality/aging
|
• most dead between 6 and 7 weeks of age
|
cardiovascular system
|
• hypertrophy
|
growth/size/body
|
• hypertrophy
|
|
• evident beginning at about 3 weeks of age
|
hematopoietic system
|
• in response to either concanavalin A (ConA) or CD3
|
homeostasis/metabolism
|
• elevated in blood
|
|
• elevated
|
|
• decreased in serum
|
immune system
|
• in response to either concanavalin A (ConA) or CD3
|
renal/urinary system
|
• hyperplasia
|
|
• loss of integrity between cells, evident at 1 week of age and progressive
|
|
• evident by 4 weeks of age
|
|
• increased size and cellularity, porgressivley worse with age
|
endocrine/exocrine glands
cellular
|
• hyperplasia
|
|
• in response to either concanavalin A (ConA) or CD3
|


Analysis Tools